All News

How the Global Initiative on Health and the Economy Can Help Us Invest in Healthy Societies

By Dominic Caruso, Executive Vice President and Chief Financial Officer of Johnson & Johnson   As a company whose mission it is to help billions of people around the world live longer, healthier and happier lives, we have long understood the tremendous impact that better health can have on an individual’s life—enabling greater contributions to […]

SpinalCyte, LLC Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration

HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts (HDFs), today announced the final results of Phase II Animal Studies for Transplantation of HDFs for Intervertebral Disc Degeneration. Previously reported was significant improvement in disc height. This final report builds on those findings […]

Doctors Urge CMS, Joint Commission to Rethink Pain Treatment to Help Stem Opioid Epidemic

April 15, 2016 – Marty Stempniak Have patient satisfaction surveys and accreditation standards inadvertently contributed tothe ongoing opioid epidemic that’s killing tens of thousands of Americans a year? A group of doctors and other health care stakeholders thinks so, and they’re petitioning the organizations responsible to get them to change how patient pain is measured and […]

Back Pain and Spine Disorders in U.S. Veterans

According to the U.S. Bone and Joint Initiative, musculoskeletal back pain is a major cause of disability for Americans. In fact, according to the National Center for Health Statistics, one in four adults suffers from chronic low back pain. This pain can stem from arthritis or inflammation, a prior spine injury or even a disc […]

StemCells, Inc. Presents Interim Results from its Phase II Pathway Study in Chronic Cervical Spinal Cord Injury at ASIA Annual Meeting

NEWARK, Calif., April 18, 2016 (GLOBE NEWSWIRE) — StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system disorders, announced today that Dr. Stephen Huhn, the Company’s Chief Medical Officer and VP of Clinical Research, presented additional details on its ongoing Phase II Pathway™ […]

What Could Help Zimmer Biomet Regain Lost Market Share?

By Sarah Collins   Zimmer Biomet’s scale of operations With Zimmer Holdings’ acquisition of Biomet in June 2015, the combinatioin of the two companies has provided a competitive edge for Zimmer Biomet. The economies of scale achieved through the acquisition give the company a broader geographic reach and market presence. The acquisition has almost doubled the […]

Tri-City Medical Center Performs 700 Spine Surgery Cases with Mazor Robotics Renaissance(R) Guidance System

ORLANDO, Fla., April 20, 2016 (GLOBE NEWSWIRE) — On April 4, Dr. Payam Moazzaz performed the 700thMazor Robotics Renaissance(R)Spine Surgery case at Tri-City Medical Center. TheRenaissance system uses mechanical guidance to help surgeons place pedicle screws and implants with unparalleled accuracy to correct conditions such as scoliosis and degenerative disc disease. Located in Oceanside, CA, […]

RTI Surgical looks to fend off proxy challenge

BY FINK DENSFORD   RTI Surgical said today it is distributing proxy material urging shareholders to “protect their investment” in RTI and fend off a proxy challenge from Krensavage Partners. In February, RTI surgical said that hedge fund group Krensavage Partners purchased approximately 3.4 million shares of stock, representing a total 6% of the company, and […]

Ortho Kinematics Secures CE Mark Approval to Support International Expansion

AUSTIN, Texas–(BUSINESS WIRE)–Ortho Kinematics‚ Inc. (OKI), a privately held healthcare diagnostics company focused on spine imaging informatics, announced today it has received CE mark approval for its lead product, Vertebral Motion Analysis “VMA”. CE mark approval is required for the commercialization of the VMA in European markets. Prior to securing CE mark approval, the VMA […]

Johnson & Johnson Reports 2016 First-Quarter Results:

NEW BRUNSWICK, N.J., April 19, 2016 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $17.5 billion for the first quarter of 2016, an increase of 0.6% as compared to the first quarter of 2015. Operational sales results increased 3.9% and the negative impact of currency was 3.3%. Domestic sales increased 7.2%. International sales […]

© 2024 MedDeviceJobs.com Powered by Careerleaf
v.4.3.2